Key result
Repeated hypobaric hypoxia exposure shows consistent symptom severity with no significant difference from recalled symptoms.
Why the study?
Hypoxia manifests as a specific spectrum of symptoms called hypoxia signature, but its repeatability and usefulness for hypoxia recognition in aircrew needed assessment.
Does repeated exposure to simulated hypobaric hypoxia produce a consistent 'hypoxia signature' of symptoms in healthy adults?
Observational (n=22)
Does repeated exposure to simulated hypobaric hypoxia produce a consistent 'hypoxia signature' of symptoms in healthy adults?
Hypoxia symptoms are highly repeatable within individuals across multiple exposures, supporting the use of a 'hypoxia signature' for hypoxia recognition training in aircrew.
Supports symptom recall consistency in hypobaric simulation; hypothesis-generating before informing aviation hypoxia protocols.
Introduction: Hypoxia, often referred to as “silent killer,” a common aeromedical stressor in aviation, may have catastrophic events in-flight unless recognized well in time. On exposure to hypoxia, an individual manifests a specific spectrum of symptoms referred to as “hypoxia signature.” The present study was conducted to assess the manifestation of “hypoxia signature” on repeated exposure to simulated hypobaric hypoxia for its potential usage as a tool for hypoxia recognition. Material and Methods: Twenty-two healthy adult volunteers were subjected to a simulated altitude of 22,000 feet for a duration of 5 min in the hypobaric altitude chamber. The symptoms experienced by the participants at the said altitude were recorded using a questionnaire. The heart rate (HR) and oxygen saturation (SpO2) were recorded during the exposure. The hypoxia exposure was repeated two more times with a minimum interval of 3 weeks between each. Paired t-test was used to compare the mean values of physiological parameters (HR and SpO2) between ground level and 22000 feet recorded in all the three exposures. The hypoxia symptoms and their severity reported during the exposures were compared with those of recalled symptoms (reported after 3 weeks of exposure) using McNemar test and Wilcoxon Signed Rank test, respectively. Results: Paired t-test revealed a statistically significant increase in HR and fall in SpO2 with rise in altitude from ground level to 22000 feet. The three most common symptoms consistently observed were lightheadedness, thinking slow, and warm feeling. The common hypoxic symptoms and their severity scores reported at 22,000 feet compared with recalled counterpart during subsequent exposures did not reveal any significant differences (P > 0.05). Conclusion: There was a high degree of similarity in the frequency and severity score of symptoms between acute exposure to hypobaric hypoxia and recall indicating evidence of repeatability of symptoms across the three sessions of hypoxia exposure within the individuals. This brings out the usefulness of “hypoxia signature” as a tool for hypoxia recognition and its application in hypoxia indoctrination and training for aircrew.
No takes yet. Share an insight, caveat, or question.
Kasture et al. (2021) conducted an observational in Healthy volunteers (n=22). Simulated hypobaric hypoxia vs. Ground level and recalled symptoms was evaluated on Difference in hypoxia symptoms and severity scores between acute exposure and recalled symptoms (p=> 0.05). Repeated exposure to simulated hypobaric hypoxia at 22,000 feet produced consistent symptoms with no significant differences between acute and recalled symptom severity (P > 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: